Status:
COMPLETED
Resiliency in Total Joint Arthroplasty
Lead Sponsor:
University of Utah
Conditions:
Osteoarthritis
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The investigators primary objective is to determine how does participation in StreaMD affect patient reported outcomes after Total Hip Arthroplasty (THA) or Total Knee Arthroplasty (TKA)?
Detailed Description
Osteoarthritis is a leading cause of disability in the US. By conservative estimates, about 54 million adults in the US have doctor-diagnosed arthritis. The number of people expected to have arthritis...
Eligibility Criteria
Inclusion
- All patients aged 18 and older who are receiving a total hip or knee replacement.
Exclusion
- Patients enrolled in the MyMobility study
- Patients who do not have cell phones with text messaging capability
- Non-English speaking patients
Key Trial Info
Start Date :
March 5 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 12 2022
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT04357262
Start Date
March 5 2020
End Date
January 12 2022
Last Update
July 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Utah Orthopaedic Center
Salt Lake City, Utah, United States, 84108